At the end of August Pakistan received1,008,000 doses of COVID-19 Vaccine AstraZeneca that were donated by the United Kingdom through the COVAX facility.
COVAX is a global initiative co-led by the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi (the Vaccines Alliance) and the World Health Organization, which works with governments and manufacturers to accelerate the development, production and equitable access to COVID-19 vaccines around the world.
Sameh Elfangary, Country President for GCC and Pakistan, AstraZeneca, said “It is truly encouraging to mark the arrival of additional doses of COVID-19 Vaccine AstraZeneca to Pakistan. This donation from the United Kingdom via the COVAX facility takes us one step further in our collective fight against the pandemic and is no doubt welcomed news to the people of Pakistan. We are working with our partners at the COVAX coalition to ensure we get the COVID-19 vaccines to as many people as soon as possible and are pleased to see such positive progress.”
AstraZeneca was the first global pharmaceutical company to join COVAX in June 2020 and more than 113 million doses of the Company’s vaccine have been delivered through COVAX to date.
AstraZeneca is committed to supplying the vaccine broadly and equitably around the world at no profit during the pandemic period. To date, more than 1 billion doses of COVID-19 Vaccine AstraZeneca have been released for supply to over 170 countries around the world, and approximately two thirds have gone to low- and lower-middle-income countries. AstraZeneca is the third biggest supplier of COVID-19 vaccine doses in the world.
Since the first international launches in early 2021, the vaccine has helped prevent hundreds of thousands of hospitalizations and helped save tens of thousands of lives. (AZD1222 lives and hospitalizations saved data on file. Data on File Number: REF-117162 June 23, 2021. AstraZeneca UK Ltd.)